This is a rare type of cancer that starts in mast cells. It's a single tumor that grows locally and doesn't spread widely. It's also called mastocytoma.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Mast cell sarcoma is a very rare, aggressive cancer made of abnormal mast cells. Mast cells are immune cells found in many tissues; they normally store chemicals such as histamine and release them during allergic and inflammatory reactions. In mast cell sarcoma, malignant mast cells form a solid tumor that invades and destroys nearby tissue and can spread to other parts of the body. It is classed as one form of mastocytosis, the group of disorders in which mast cells build up abnormally. Most forms of mastocytosis affect the skin or behave slowly. Mast cell sarcoma is different: it grows as a destructive mass. Bone is the most common site, including the spine, pelvis, legs and skull, followed by the digestive tract, lymph nodes and skin. Symptoms usually come from the tumor itself, such as bone pain, a growing lump, or abdominal pain and anemia (a low red blood cell count) when the bowel is involved. Only a few dozen human cases have been described in detail, so much of what is known comes from individual case reports.
No cause or avoidable trigger is known. Most cases appear on their own, without any earlier mast cell disease. A smaller number develop in people who already have mastocytosis, sometimes many years after it began in the skin during childhood. Mast cell disorders are often driven by changes in a gene called KIT, which controls mast cell growth. These are acquired changes in the tumor cells, not inherited ones, and mast cell sarcoma does not usually run in families; only one familial case has been reported. It can occur at any age, from young children to older adults, and affects men and women about equally.
Diagnosis depends on a biopsy, a sample of the tumor examined under a microscope. Because the cancer cells often look very unusual, mast cell sarcoma is easy to mistake for lymphoma, leukemia or other tumors. Pathologists confirm it with special stains that identify mast cell proteins, including tryptase and CD117 (the protein made by the KIT gene). A second opinion from a pathologist experienced with mast cell disease can be valuable, since the first reading is often wrong. The tumor is then tested for changes in the KIT gene. Full sequencing of the gene is recommended rather than a test for one common change alone, because the specific change can determine whether certain targeted medicines are likely to work. Imaging such as CT, MRI or PET-CT shows where the disease is and how far it has spread. A blood test for tryptase, an enzyme released by mast cells, is often raised and can be followed over time. A bone marrow biopsy checks whether the disease has spread to the marrow or turned into mast cell leukemia.
There is no standard treatment for mast cell sarcoma, because it is too rare for clinical trials. Care is usually guided by a specialist center and often combines approaches. Surgery to remove a tumor that has not spread, sometimes followed by radiation to the area, has produced remissions, though in many reported cases the cancer later returned. Targeted drugs called KIT inhibitors block the growth signal that drives abnormal mast cells. Imatinib (Gleevec), a daily tablet, has shrunk some tumors that lack a KIT change called D816V, with responses lasting from a few months to more than a year; tumors with D816V generally resist it. Other KIT-blocking drugs have been tried in single cases, with mixed results. Standard chemotherapy has usually had limited effect. High-dose steroids can ease symptoms briefly. For some people, a stem cell transplant from a donor is being considered as a way to aim for longer-lasting control, but there is too little experience with it in this disease to know how well it works. Because evidence is so limited, asking about clinical trials or referral to a mastocytosis center is often part of planning.
In the published cases, mast cell sarcoma has usually been hard to control. In a review of 23 cases, median survival was less than 18 months, and about a third of people developed mast cell leukemia, where malignant mast cells spread through the blood and bone marrow. These figures come from a small number of reports, some before targeted medicines were widely used, so they cannot predict an individual outcome. A few people whose tumor was found early and fully removed have done well. Treatment often involves several steps, with regular imaging, blood tests and sometimes repeat biopsies to check whether the disease is responding or returning. Because bone is commonly involved, managing pain can be a large part of daily care. Palliative care, which treats pain, fatigue and other symptoms and can be given at any stage of an illness, can be used alongside cancer treatment to support quality of life for the person and their family.
Arrange a medical evaluation for bone pain that keeps getting worse, a lump that is growing, or ongoing abdominal pain with tiredness from anemia. If you already have mastocytosis, report any new symptom like these to your specialist, since mast cell sarcoma can occasionally develop from it. If you are being treated, contact your care team promptly about new or worsening pain or a new lump, which can signal that the disease is growing or returning. If the tumor involves the spine, new weakness or numbness in the legs, or new trouble controlling or passing urine or stool, needs emergency care right away, because a tumor pressing on the spinal cord can cause permanent damage if not treated quickly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Mast-Cell Sarcoma is like, what's helped you, or ask the community a question.